Stanley-Laman Group Ltd decreased its stake in Akebia Therapeutics (AKBA) by 11.8% based on its latest 2018Q3 regulatory filing with the SEC. Stanley-Laman Group Ltd sold 40,307 shares as the company’s stock rose 15.91% while stock markets declined. The institutional investor held 301,182 shares of the health care company at the end of 2018Q3, valued at $2.66M, down from 341,489 at the end of the previous reported quarter. Stanley-Laman Group Ltd who had been investing in Akebia Therapeutics for a number of months, seems to be less bullish one the $866.14M market cap company. The stock increased 3.78% or $0.27 during the last trading session, reaching $7.41. About 675,545 shares traded. Akebia Therapeutics, Inc. (NASDAQ:AKBA) has declined 42.65% since February 28, 2018 and is downtrending. It has underperformed by 42.65% the S&P500. Some Historical AKBA News: 03/04/2018 – Akebia Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4); 21/05/2018 – Akebia Therapeutics Presenting at UBS Conference Tomorrow; 09/05/2018 – Akebia Therapeutics 1Q Rev $45.9M; 12/03/2018 Akebia Therapeutics 4Q Rev $87.3M; 15/05/2018 – Ecor1 Capital Buys New 2.5% Position in Akebia Therapeutics; 15/05/2018 – Akebia Therapeutics at UBS Global Healthcare Conference May 22; 12/03/2018 – Akebia Therapeutics 4Q Net $12.3M; 22/03/2018 – AKEBIA THERAPEUTICS TO OFFER ABOUT $85M OF SHRS; 14/05/2018 – Laurion Capital Buys New 1.7% Position in Akebia Therapeutics; 26/03/2018 – Akebia Therapeutics Presenting at Conference Tomorrow

Teachers Insurance & Annuity Association Of America decreased its stake in Equinix Inc (EQIX) by 0.76% based on its latest 2018Q3 regulatory filing with the SEC. Teachers Insurance & Annuity Association Of America sold 782 shares as the company’s stock declined 10.82% with the market. The institutional investor held 101,494 shares of the consumer services company at the end of 2018Q3, valued at $43.94 million, down from 102,276 at the end of the previous reported quarter. Teachers Insurance & Annuity Association Of America who had been investing in Equinix Inc for a number of months, seems to be less bullish one the $33.62B market cap company. The stock decreased 1.81% or $7.69 during the last trading session, reaching $418.15. About 2,668 shares traded. Equinix, Inc. (NASDAQ:EQIX) has declined 15.07% since February 28, 2018 and is downtrending. It has underperformed by 15.07% the S&P500.

Stanley-Laman Group Ltd, which manages about $747.00M and $406.97 million US Long portfolio, upped its stake in Honeywell Automation India Inr 10.0 by 1,872 shares to 6,346 shares, valued at $1.81M in 2018Q3, according to the filing.

Investors sentiment decreased to 0.89 in Q3 2018. Its down 0.46, from 1.35 in 2018Q2. It worsened, as 19 investors sold AKBA shares while 36 reduced holdings. 15 funds opened positions while 34 raised stakes. 38.94 million shares or 2.43% less from 39.91 million shares in 2018Q2 were reported. Omers Administration reported 0.02% of its portfolio in Akebia Therapeutics, Inc. (NASDAQ:AKBA). First Manhattan Com reported 0.04% stake. State Common Retirement Fund reported 46,800 shares stake. Ameritas Investment Prtnrs, a Nebraska-based fund reported 3,813 shares. Moreover, Amer Group has 0% invested in Akebia Therapeutics, Inc. (NASDAQ:AKBA). Tocqueville Asset LP has invested 0% in Akebia Therapeutics, Inc. (NASDAQ:AKBA). Rice Hall James & Assoc Llc invested in 0.01% or 40,220 shares. Mutual Of America Cap Mngmt Limited Liability reported 134,533 shares. California Public Employees Retirement System accumulated 0% or 63,026 shares. Goldman Sachs Grp Inc holds 123,625 shares. Ubs Asset Management Americas stated it has 0% of its portfolio in Akebia Therapeutics, Inc. (NASDAQ:AKBA). State Street owns 2.28M shares. 634,396 are owned by Northern Tru Corp. Point72 Asset Mgmt LP holds 0.01% of its portfolio in Akebia Therapeutics, Inc. (NASDAQ:AKBA) for 298,212 shares. Citadel Advsrs Lc reported 991,776 shares.

More notable recent Akebia Therapeutics, Inc. (NASDAQ:AKBA) news were published by: Nasdaq.com which released: “Akebia Therapeutics (AKBA) Upgraded to Buy: Here’s What You Should Know – Nasdaq” on January 30, 2019, also with their article: “71 Biggest Movers From Friday – Benzinga” published on February 25, 2019, Streetinsider.com published: “Baupost’s 13F Shows New Stakes in eBay (EBAY), Akebia (AKBA), CBS (CBS) (more…) – StreetInsider.com” on February 13, 2019. More interesting news about Akebia Therapeutics, Inc. (NASDAQ:AKBA) were released by: Seekingalpha.com and their article: “Akebia Therapeutics and Keryx Biopharmaceuticals complete merger – Seeking Alpha” published on December 13, 2018 as well as Seekingalpha.com‘s news article titled: “FDA OK’s three-year NCE exclusivity for Akebia’s Auryxia, says no to five years – Seeking Alpha” with publication date: January 31, 2019.

Analysts await Akebia Therapeutics, Inc. (NASDAQ:AKBA) to report earnings on March, 11. They expect $-0.80 earnings per share, down 420.00% or $1.05 from last year’s $0.25 per share. After $-0.46 actual earnings per share reported by Akebia Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 73.91% negative EPS growth.

Investors sentiment increased to 1.34 in Q3 2018. Its up 0.07, from 1.27 in 2018Q2. It increased, as 23 investors sold EQIX shares while 165 reduced holdings. 72 funds opened positions while 180 raised stakes. 75.93 million shares or 0.07% more from 75.88 million shares in 2018Q2 were reported. Texas Permanent School Fund owns 0.11% invested in Equinix, Inc. (NASDAQ:REIT) for 17,848 shares. Carroll Associate holds 0% in Equinix, Inc. (NASDAQ:REIT) or 32 shares. Meag Munich Ergo Kapitalanlagegesellschaft Mbh accumulated 550 shares. Investors holds 0.07% or 364,556 shares. Gagnon Advsr Limited Liability Company holds 2.08% of its portfolio in Equinix, Inc. (NASDAQ:REIT) for 8,032 shares. Mai Capital Mngmt invested in 949 shares. New Amsterdam Ptnrs Llc holds 0.09% or 815 shares in its portfolio. Apg Asset Mngmt Nv holds 0.01% or 22,499 shares. Tarbox Family Office, California-based fund reported 16 shares. Tiaa Cref Inv Limited Co has 0.08% invested in Equinix, Inc. (NASDAQ:REIT) for 290,605 shares. Sg Americas Ltd Llc stated it has 0.07% of its portfolio in Equinix, Inc. (NASDAQ:REIT). Amp Capital Limited reported 0.48% in Equinix, Inc. (NASDAQ:REIT). Emerald Advisers Inc Pa invested 0.04% of its portfolio in Equinix, Inc. (NASDAQ:REIT). Aqr Cap Management Limited holds 0.04% of its portfolio in Equinix, Inc. (NASDAQ:REIT) for 92,403 shares. Mackenzie Fin Corporation holds 0% or 1,371 shares.

Since September 4, 2018, it had 0 buys, and 9 insider sales for $9.10 million activity. Shares for $478,833 were sold by VAN CAMP PETER. 3,551 shares valued at $1.35M were sold by Schwartz Eric on Tuesday, January 15. STROHMEYER KARL sold $1.47 million worth of Equinix, Inc. (NASDAQ:REIT) on Tuesday, January 15. Another trade for 2,785 shares valued at $1.06M was sold by TAYLOR KEITH D. Meyers Charles J also sold $2.15 million worth of Equinix, Inc. (NASDAQ:REIT) on Tuesday, January 15. Lee Yau Tat sold $1.07 million worth of stock.